Back to Search Start Over

Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of Origin.

Authors :
Espinet E
Gu Z
Imbusch CD
Giese NA
Büscher M
Safavi M
Weisenburger S
Klein C
Vogel V
Falcone M
Insua-Rodríguez J
Reitberger M
Thiel V
Kossi SO
Muckenhuber A
Sarai K
Lee AYL
Backx E
Zarei S
Gaida MM
Rodríguez-Paredes M
Donato E
Yen HY
Eils R
Schlesner M
Pfarr N
Hackert T
Plass C
Brors B
Steiger K
Weichenhan D
Arda HE
Rooman I
Kopp JL
Strobel O
Weichert W
Sprick MR
Trumpp A
Source :
Cancer discovery [Cancer Discov] 2021 Mar; Vol. 11 (3), pp. 638-659. Date of Electronic Publication: 2020 Oct 15.
Publication Year :
2021

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is characterized by extensive desmoplasia, which challenges the molecular analyses of bulk tumor samples. Here we FACS-purified epithelial cells from human PDAC and normal pancreas and derived their genome-wide transcriptome and DNA methylome landscapes. Clustering based on DNA methylation revealed two distinct PDAC groups displaying different methylation patterns at regions encoding repeat elements. Methylation <superscript>low</superscript> tumors are characterized by higher expression of endogenous retroviral transcripts and double-stranded RNA sensors, which lead to a cell-intrinsic activation of an interferon signature (IFNsign). This results in a protumorigenic microenvironment and poor patient outcome. Methylation <superscript>low</superscript> /IFNsign <superscript>high</superscript> and Methylation <superscript>high</superscript> /IFNsign <superscript>low</superscript> PDAC cells preserve lineage traits, respective of normal ductal or acinar pancreatic cells. Moreover, ductal-derived Kras <superscript>G12D</superscript> / Trp53 <superscript>-/-</superscript> mouse PDACs show higher expression of IFNsign compared with acinar-derived counterparts. Collectively, our data point to two different origins and etiologies of human PDACs, with the aggressive Methylation <superscript>low</superscript> /IFNsign <superscript>high</superscript> subtype potentially targetable by agents blocking intrinsic IFN signaling. SIGNIFICANCE: The mutational landscapes of PDAC alone cannot explain the observed interpatient heterogeneity. We identified two PDAC subtypes characterized by differential DNA methylation, preserving traits from normal ductal/acinar cells associated with IFN signaling. Our work suggests that epigenetic traits and the cell of origin contribute to PDAC heterogeneity. This article is highlighted in the In This Issue feature, p. 521 .<br /> (©2020 American Association for Cancer Research.)

Details

Language :
English
ISSN :
2159-8290
Volume :
11
Issue :
3
Database :
MEDLINE
Journal :
Cancer discovery
Publication Type :
Academic Journal
Accession number :
33060108
Full Text :
https://doi.org/10.1158/2159-8290.CD-20-1202